{{medical}}
{{Drugbox
| Watchedfields = changed
| verifiedrevid = 443519547
| IUPAC_name = 3-(2-chloro-10''H''-phenothiazin-10-yl)-''N'',''N''-dimethyl-propan-1-amine
| image = Chlorpromazine.svg
| alt = Skeletal formula of chlorpromazine
| width = 222
| image2 = Chlorpromazine-3D-balls.png
| alt2 = Ball-and-stick model of the chlorpromazine molecule
<!--Clinical data-->
| tradename = Largactil, Thorazine, others
| Drugs.com = {{drugs.com|monograph|chlorpromazine-hydrochloride}}
| licence_US = Chlorpromazine
| MedlinePlus = a682040
| pregnancy_AU = C
| pregnancy_US = C
| legal_AU = S4
| legal_CA = Rx-only
| legal_UK = POM
| legal_US = Rx-only
| routes_of_administration = [[口服|口服]]（藥丸或糖漿）、[[栓剂|肛門塞劑]]、[[肌肉注射|肌肉注射]]、[[靜脈注射|靜脈注射]]
<!--Pharmacokinetic data-->
| bioavailability = 10–80%（口服，視體質而定）<ref name=TGA>{{cite web|title=PRODUCT INFORMATION LARGACTIL|work=TGA eBusiness Services|publisher=Sanofi Aventis Pty Ltd|date=28 August 2012|accessdate=8 December 2013|url=https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2010-PI-05882-3|format=PDF|deadurl=no|archiveurl=https://web.archive.org/web/20170330162812/https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2010-PI-05882-3|archivedate=30 March 2017}}</ref>
| protein_bound = 90–99%<ref name = TGA/>
| metabolism = [[肝臟|肝臟]]，大多經[[CYP2D6|CYP2D6]]<ref name = TGA/>
| elimination_half-life = 30 小時<ref name=AHFS2015/>
| excretion = 尿液（24小時內排除43–65%）<ref name = TGA/>
<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 50-53-3
| CAS_number_comment = 自由基團
| CAS_number2 = 69-09-0
| CAS_number2_comment = 鹽酸鹽
| ATC_prefix = N05
| ATC_suffix = AA01
| PubChem = 2726
| IUPHAR_ligand = 83
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB00477
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 2625
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = U42B7VYA4P
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D00270
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 3647
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 71
<!--Chemical data-->
| C=17 | H=19 | Cl=1 | N=2 | S=1
| molecular_weight = 318.86 g/mol（自由基團）<br/>355.33 g/mol（鹽酸鹽）
| smiles = CN(C)CCCN1c2ccccc2Sc3c1cc(cc3)Cl
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C17H19ClN2S/c1-19(2)10-5-11-20-14-6-3-4-7-16(14)21-17-9-8-13(18)12-15(17)20/h3-4,6-9,12H,5,10-11H2,1-2H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = ZPEIMTDSQAKGNT-UHFFFAOYSA-N
}}
<!-- Definition and medical uses -->

'''氯丙嗪'''（Chlorpromazine，簡稱'''CPZ'''），常見商標名 '''Thorazine''' 或 '''Largactil'''，是一種[[抗精神病药|精神科藥物]]<ref name=AHFS2015/>。本品一般用於治療[[精神分裂症|精神分裂症]]等[[思覺失調|思覺失調]]<ref name=AHFS2015/>。其他用途還可用做作治療[[躁鬱症|躁鬱症]]、[[注意力不足過動症|過動症]]、[[恶心|恶心]]、[[呕吐|呕吐]]、術前焦慮，或是其他方法無法控制的[[打嗝|打嗝]]症狀等等<ref name=AHFS2015/>。本品可以口服、[[肌肉注射|肌肉注射]]或[[靜脈注射|靜脈注射]]<ref name=AHFS2015/>。

<!-- Side effects and mechanism-->
常見副作用包含[[錐體外症候群|錐體外症候群]]、{{tsl|en|sedation|鎮靜|嗜睡}}、口乾、[[姿位性低血壓|姿位性低血壓]]，以及體重增加等等<ref name=AHFS2015/>。嚴重副作用可能導致{{tsl|en|tardive dyskinesia|遲發性不自主運動}}等永久運動功能障礙、{{tsl|en|neuroleptic malignant syndrome|抗精神藥物惡性症候群}}、以及[[白细胞减少症|白细胞减少症]]<ref name=AHFS2015/>。因[[失智症|失智症]]導致精神錯亂的老年人用藥可能會增加死亡風險<ref name=AHFS2015/>。[[妊娠|妊娠]]期間用藥的安全性迄今不明<ref name=AHFS2015/>。本品屬於{{tsl|en|typical antipsychotic|典型抗憂鬱藥物}}<ref name=AHFS2015/>。其作用機制尚未明朗，但可能與其具{{tsl|en|dopamine antagonist|多巴胺受體拮抗劑|}}的活性有關<ref name=AHFS2015/>。本品亦具有{{tsl|en|antiserotonergic|抗血清素活性|抗血清素}}以及[[抗組織胺藥|抗組織胺]]的活性<ref name="AHFS2015">{{cite web|url=http://www.drugs.com/monograph/chlorpromazine-hydrochloride.html|title=Chlorpromazine Hydrochloride|accessdate=Dec 1, 2015|author=|date=|publisher=The American Society of Health-System Pharmacists|archiveurl=https://web.archive.org/web/20151208163938/http://www.drugs.com/monograph/chlorpromazine-hydrochloride.html|archivedate=8 December 2015|deadurl=no}}</ref>。

<!-- History, society and culture -->
本品最早於1950年發現，為第一種精神疾患藥物<ref name="history05">{{Cite journal|doi=10.1080/10401230591002002|last1=López-Muñoz |first1=Francisco |last2=Alamo |first2=Cecilio |last3=Cuenca|first3=Eduardo|last4=Shen |first4=Winston W. |last5=Clervoy |first5=Patrick |last6=Rubio |first6=Gabriel |year=2005 |title=History of the discovery and clinical introduction of chlorpromazine |journal=Annals of Clinical Psychiatry |volume=17 |issue=3|pages=113–35|pmid=16433053}}</ref><ref name=Ban2007>{{cite journal|last1=Ban|first1=TA|title=Fifty years chlorpromazine: a historical perspective.|journal=Neuropsychiatric disease and treatment|date=August 2007|volume=3|issue=4|pages=495–500|pmid=19300578|pmc=2655089}}</ref>。本品列名於[[世界卫生组织基本药物标准清单|世界卫生组织基本药物标准清单]]之中，為基礎公衛體系必備藥物之一<ref name=WHO19th>{{cite web|title=WHO Model List of Essential Medicines (19th List)|url=http://www.who.int/medicines/publications/essentialmedicines/EML_2015_FINAL_amended_NOV2015.pdf?ua=1|work=World Health Organization|accessdate=8 December 2016|date=April 2015|deadurl=no|archiveurl=https://web.archive.org/web/20161213052708/http://www.who.int/medicines/publications/essentialmedicines/EML_2015_FINAL_amended_NOV2015.pdf?ua=1|archivedate=13 December 2016}}</ref>。氯丙嗪的發現為精神醫療的{{tsl|en|history of psychiatry|精神醫學歷史|重大里程碑}}<ref>{{cite journal|last1=López-Muñoz|first1=F|last2=Alamo|first2=C|last3=Cuenca|first3=E|last4=Shen|first4=WW|last5=Clervoy|first5=P|last6=Rubio|first6=G|title=History of the discovery and clinical introduction of chlorpromazine.|journal=Annals of Clinical Psychiatry|date=2005|volume=17|issue=3|pages=113–35|pmid=16433053|doi=10.1080/10401230591002002}}</ref><ref>{{cite book|last1=Shorter|first1=Edward|title=A historical dictionary of psychiatry|date=2005|publisher=Oxford University Press|location=New York|isbn=9780198039235|page=6|url=https://books.google.com/books?id=M49pEDoEpl0C&pg=PA6|deadurl=no|archiveurl=https://web.archive.org/web/20170214213428/https://books.google.com/books?id=M49pEDoEpl0C&pg=PA6|archivedate=14 February 2017}}</ref>。本品屬於[[通用名藥物|通用名藥物]]<ref name=AHFS2015/>，其於[[開發中國家|開發中國家]]的每日劑量批發價約介於 0.02 至 0.12 美金之間<ref>{{cite web|title=Chlorpromazine HCL|url=http://erc.msh.org/dmpguide/resultsdetail.cfm?language=english&code=CPZ100T&s_year=2014&year=2014&str=100%20mg&desc=Chlorpromazine%20HCl&pack=new&frm=TAB-CAP&rte=PO&class_code2=24%2E1%2E&supplement=&class_name=%2824%2E1%2E%29Medicines%20used%20in%20psychotic%20disorders%3Cbr%3E|website=International Drug Price Indicator Guide|accessdate=1 December 2015|deadurl=yes|archiveurl=https://web.archive.org/web/20170329013315/http://erc.msh.org/dmpguide/resultsdetail.cfm?language=english&code=CPZ100T&s_year=2014&year=2014&str=100%20mg&desc=Chlorpromazine%20HCl&pack=new&frm=TAB-CAP&rte=PO&class_code2=24.1.&supplement=&class_name=%2824.1.%29Medicines%20used%20in%20psychotic%20disorders%3Cbr%3E|archivedate=2017年3月29日}}</ref>。在美國同樣劑量則約需 2 美金<ref name=AHFS2015/>。

==藥理學==
现在氯丙嗪被归入第一代[[抗精神病药|抗精神病药]]，它们的药理机制是阻断脑内[[多巴胺|多巴胺]][[受体|受体]]，从而发挥抗精神病作用。

==不良反應==
该类药物一般都伴有锥体外系副作用。针剂的体位性[[低血压|低血压]][[副作用|副作用]]较明显。长期服用后戒断会出现肌肉[[抽搐|抽搐]]。

==劑型及用量==
有片剂和针剂，25mg/片，50mg/针。

用于治疗精神病时起始剂量较低，根据病人情况逐渐加量至治疗剂量，治疗剂量一般在300mg至600mg之间。该药有较强的镇静作用，故也常用于镇静。针剂通常用于不合作病人，另外针剂通常与[[鹽酸異丙嗪|鹽酸異丙嗪]]（也叫非那根）合用，组成冬非合剂。

==註釋==
{{reflist|2}}

==參考文獻==
{{refbegin|2}}
*{{cite book |last=Baldessarini |first=Ross J. |coauthors=Frank I. Tarazi |editor=Laurence Brunton, John Lazo, Keith Parker (eds.) |title=[[Goodman_&_Gilman's_The_Pharmacological_Basis_of_Therapeutics|Goodman & Gilman's The Pharmacological Basis of Therapeutics]] |edition=11<sup>th</sup> |year=2006 |publisher=[[McGraw-Hill|McGraw-Hill]] |location=New York |isbn=978-0071422802|pages= |chapter=Pharmacotherapy of Psychosis and Mania }}
*Bezchlibnyk-Butler, K. Z. ''Clinical Handbook of Psychotropic Drugs'' (German Edition)
*''Rote Liste'' (German Drug Compendium)
*Benkert, O. and H. Hippius. ''Psychiatrische Pharmakotherapie'' (German. 6th Edition, 1996)
*''Physician's Desktop Reference'' (2004)
*Heinrich, K. ''Psychopharmaka in Klinik und Praxis'' (German, 2nd Edition, 1983)
*Römpp, ''Chemielexikon'' (German, 9th Edition)
*NINDS Information Homepage (see External links section)
*Plumb, Dondal C. ''Plumb's Veterinary Drug Handbook'' (Blackwell, 5th Edition, 2005)
*{{cite web |url=http://www.clarkprosecutor.org/html/death/methods.htm |title=Methods of Execution |accessdate=2008-08-03 |work=Clark County, IN Prosecuting Attorney web page |archive-date=2008-09-14 |archive-url=https://web.archive.org/web/20080914164956/http://www.clarkprosecutor.org/html/death/methods.htm |dead-url=no }}
{{refend}}

==外部連結==
* [http://www.nlm.nih.gov/medlineplus/druginfo/meds/a682040.html Medlineplus article on chlorpromazine] {{Wayback|url=http://www.nlm.nih.gov/medlineplus/druginfo/meds/a682040.html |date=20100615175522 }}
* [http://www.ninds.nih.gov/disorders/tardive/tardive.htm National Institute of Neurological Disorders and Stroke (NINDS) Tardive Dyskinesia information page] {{Wayback|url=http://www.ninds.nih.gov/disorders/tardive/tardive.htm |date=20120427104252 }}
* [http://druginfo.nlm.nih.gov/drugportal/dpdirect.jsp?name=Chlorpromazine U.S. National Library of Medicine: Drug Information Portal - Chlorpromazine] {{Wayback|url=http://druginfo.nlm.nih.gov/drugportal/dpdirect.jsp?name=Chlorpromazine |date=20100615040949 }}

{{止吐剂}}
{{Sigmaergics}}
{{Hypnotics and sedatives}}

[[Category:精神药物|Category:精神药物]]
[[Category:世界卫生组织基本药物|Category:世界卫生组织基本药物]]
[[Category:肝毒素|Category:肝毒素]]